Urinary tract infections (UTI) are one of the most frequent problems in hospitalized patients. Infections caused by the gram-negative bacteria which produces Extended-spectrum β-lactamases (ESBL) have become the severe problem in the hospitals across the globe. Increase in extended-spectrum betalactamase producing organisms in recent years has led to the limitation of treatment option. This study was designed to evaluate the occurrence of different uropathogens producing ESBL, its antibiogram and Multi-drug resistance (MDR) status in hospitalized patients. 885 non-repetitive urine samples were collected in the study. | Multi-drug resistance and extended-spectrum β-lactamase production in uropathogens from hospitalized patients in Gurugram India
